You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alrn-6924

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022

Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

Recruiting
  • Prevention of Chemotherapy-induced Myelosuppression
  • ALRN-6924
  • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
  • Tamarac, Florida
  • +14 more
Jan 31, 2023

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • ALRN-6924
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Acute Myeloid Leukemia, MDS Trial in United States (ALRN-6924, ALRN-6924 in combination with cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • ALRN-6924
  • ALRN-6924 in combination with cytarabine
  • Denver, Colorado
  • +5 more
Nov 18, 2019